The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

The GNAS1 T393C polymorphism and lack of clinical prognostic value in chronic lymphocytic leukemia

Author

  • Mohd Arifin Kaderi
  • Fiona Murray
  • Mattias Jansson
  • Mats Merup
  • Karin Karlsson
  • Goeran Ross
  • Anna Aleskog
  • Gerard Tobin

Summary, in English

Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease with no known single predisposing genetic factor shown in all cases. Recently, a single nucleotide polymorphism (SNP) T393C in the GNAS1 gene has been reported to have a clinical impact on CLL progression and overall survival. In order to further investigate the T393C SNP in CLL, we have genotyped 279 CLL cases and correlated the genotypes to clinical outcome and other known prognostic factors such as the immunoglobulin heavy chain variable (IGHV) gene mutation status and CD38 expression. In the present study, no difference in overall survival or time to treatment was observed in the CLL patients with the different genotypes in contrast to the previous report. Furthermore, no correlation was observed with the T393C genotypes and IGHV mutational status, Binet stage or CD38 in this cohort. In summary, our data does not support the use of the T393C GNAS SNP as a clinical prognostic factor in CLL.

Department/s

Publishing year

2008

Language

English

Pages

984-987

Publication/Series

Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis

Volume

32

Issue

6

Document type

Journal article

Publisher

Elsevier

Topic

  • Cancer and Oncology

Keywords

  • leukemia prognosis
  • GNAS1 T393C single nucleotide polymorphism
  • chronic lymphocytic

Status

Published

ISBN/ISSN/Other

  • ISSN: 1873-5835